Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 5Gastrointestinal Stromal Tumors 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Bone Neoplasms 2Bile Duct Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neurofibrosarcoma 1Neoplasms, Connective and Soft Tissue 1Malignant mesenchymal tumor 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Liposarcoma 1Leukemia 1Leiomyosarcoma 1Laryngeal Neoplasms 1

Interventions

Doxorubicin 3lentiviral minigene vaccine of COVID-19 coronavirus 1eltrombopag 1camrelizumab 1apatinib 1Vinorelbine 1Trabectedin 1Temozolomide 1Observation 1Methotrexate 1Irinotecan 1FANG vaccine 1Dexamethasone 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Connective and Soft Tissue × Observation × Sarcoma × Clear all
NCT02677961 2026-02-11

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Ohio State University Comprehensive Cancer Center

Recruiting
1,500 enrolled
Sarcoma

Bone Neoplasms, Sarcoma, Neoplasms, Connective and Soft Tissue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡